Skip to main content
· 2/13/2001

Biovail Corporation International, Biovail Laboratories,inc., and Galephar P.R., Inc. Ltd. v. Andrx Pharmaceuticals, Inc.

Citations

  • 239 F.3d 1297
  • 57 U.S.P.Q. 2d (BNA) 1813
  • 2001 U.S. App. LEXIS 2092
  • 2001 WL 118289

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

  • using 15 earlier application prosecution history to restrictively construed the term “admixiture” as requiring 16 a homogenous admixture
  • “[W]e review both the specification and applicable prosecution history to determine whether the patentee defined claim terminology in a manner inconsistent with its ordinary meaning.”
  • \[W]e review both the specification and applicable prosecution history to determine whether the patentee defined claim terminology in a manner inconsistent with its ordinary meaning.\
  • “Literal infringement requires a patentee to prove by a preponderance of the evidence that every limitation of the asserted claim is literally met... .”
  • “Literal infringement requires a patentee to prove by a preponderance of the evidence that every limitation of the asserted claim is literally met.”
  • “As a general proposition, a limitation that does not exist in a claim should not be read into that claim.”

Source: CourtListener parenthetical corpus (CC0).

Judges: Newman, Clevenger, Gajarsa

Read full opinion on CourtListener

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.